Permission AI: A Secure Multi-Modal Architectural Framework for Intelligent Digital Assistance
International Journal of Science, Strategic Management and Technology · 02.05.2026 · 02 (05) · 1-9
DOI: 10.55041/ijsmt.v2i5.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Science, Strategic Management and Technology, online erschienen am 02.05.2026. Verfasst von Dr. NISHA DAYANA T R und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Modern conversational AI platforms face two critical challenges: the high latency of multi-modal inference and the inherent privacy risks of unmanaged data access. This paper presents Permission AI, a secure architectural framework that integrates permissionbased access control with highperformance vision analysis. By leveraging NVIDIA GPU acceleration for visioninstruct models (Llama 3.2 Vision) and a JWT-secured Node.js backend, the system provides a low-latency, private environment for intelligent digital assistance. Our implementation demonstrates that localizing permission logic and accelerating vision inference can reduce end-to-end response times while maintaining a robust security posture for sensitive user queries.
Zitieren
APA
R, D. N. D. T., & P, S. (2026). Permission AI: A Secure Multi-Modal Architectural Framework for Intelligent Digital Assistance. International Journal of Science, Strategic Management and Technology, 02(05), 1-9. https://doi.org/10.55041/ijsmt.v2i5.021
Vancouver
R DNDT, P S. Permission AI: A Secure Multi-Modal Architectural Framework for Intelligent Digital Assistance. International Journal of Science, Strategic Management and Technology. 2026;02(05):1-9. doi:10.55041/ijsmt.v2i5.021
BibTeX
@article{R2026,
author = {R, Dr. NISHA DAYANA T and P, Sivasakthi.},
title = {Permission AI: A Secure Multi-Modal Architectural Framework for Intelligent Digital Assistance},
journal = {International Journal of Science, Strategic Management and Technology},
year = {2026},
volume = {02},
number = {05},
pages = {1--9},
doi = {10.55041/ijsmt.v2i5.021}
}
EUVIMED